Previous research has shown that individuals with frailty exhibit elevated levels of inflammatory markers such as C-reactive protein (CRP), interleukin-1 beta (IL-1β), and IL-6, accompanied by chronic systemic inflammation and increased monocyte counts (5, 20). This evidence concerns the gene CRP and inflammatory response.